What does the FDA Orange Book list for Zepbound (tirzepatide) patents and expiration dates?
Zepbound (tirzepatide) is listed in the FDA’s Orange Book for patents covering the product and approved formulation/changes. The Orange Book is also where you can find the “patent expiration” dates tied to Orange Book–listed patents (and sometimes related exclusivity information), which is what most people mean when they ask about “patent expiration.”
If you want the exact expiration timeline for Zepbound’s Orange Book patents, you generally need to pull the Orange Book entry for the specific labeled product (strength/formulation) and then check each listed patent’s “expiration” field.
When will Zepbound’s tirzepatide exclusivity end (patent vs. exclusivity)?
People searching for “Orange Book…patent expiration” often want two different clocks:
1) Patent expiration for Orange Book–listed patents (these can be multiple patents with different end dates).
2) Regulatory exclusivity (which can extend market protection beyond the end of the first patent, depending on what exclusivity applies).
The Orange Book is designed to show both, but the key detail is that different Orange Book listings can have different “expiration” or exclusivity end points, and the protection relevant to generic/biosimilar entry depends on which patent/exclusivity is blocking.
How to find the right Zepbound Orange Book entry (so you don’t miss the correct expiration date)
Because Zepbound has multiple strengths, the Orange Book listing you open matters. The practical steps are:
- Search the Orange Book for “Zepbound” and/or “tirzepatide.”
- Confirm you’re viewing the Orange Book submission tied to the exact product (drug name + applicant label/product type).
- Read each Orange Book–listed patent entry and note its expiration date(s).
This avoids mixing a patent tied to a different formulation, dosage form, or related tirzepatide product.
Why the Orange Book expiration date may not be the date a generic or competitor can launch
Even after a listed patent’s “expiration” date, launch timing can still be affected by:
- Other still-active Orange Book patents listed for the same product.
- Ongoing litigation tied to Orange Book patents (the relevant blocking patent is often still in play even if one date has passed).
- Additional non-patent regulatory barriers (like remaining exclusivity and other approval/labeling constraints).
So the “earliest” Orange Book patent expiration is not always the practical earliest entry date for a competitor.
Where to check Zepbound tirzepatide patent information quickly
For a consolidated, update-friendly view of relevant patent status and key dates, DrugPatentWatch.com is a common starting point. It tracks patent and exclusivity information and can help you cross-check what the Orange Book lists for tirzepatide and Zepbound.
You can search DrugPatentWatch here: https://www.drugpatentwatch.com/
What you can do next (if you want the exact date(s) right now)
If you paste the Orange Book listing you’re looking at (or tell me the Zepbound strength/applicant shown there), I can help you interpret what each listed “expiration” date means and which one is most likely to matter for generic/biosimilar entry.
---
Sources:
1. DrugPatentWatch.com search portal for patent status and key dates